Literature DB >> 19176361

Donor lymphocyte infusions in amyloid light chain amyloidosis: induction of a "graft-versus-plasma cell-dyscrasia effect".

Stefan O Schonland, Nicolaus Kröger, Christine Wolschke, Peter Dreger, Anthony D Ho, Ute Hegenbart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19176361      PMCID： PMC2649345          DOI： 10.3324/haematol.13364

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning.

Authors:  Charles Crawley; Simona Iacobelli; Bo Björkstrand; Jane F Apperley; Dietger Niederwieser; Gösta Gahrton
Journal:  Blood       Date:  2006-12-07       Impact factor: 22.113

2.  Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation.

Authors:  Vaishali Sanchorawala; Martha Skinner; Karen Quillen; Kathleen T Finn; Gheorghe Doros; David C Seldin
Journal:  Blood       Date:  2007-08-02       Impact factor: 22.113

3.  Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.

Authors:  Stefan O Schönland; Henk Lokhorst; Agnes Buzyn; Veronique Leblond; Ute Hegenbart; Giuseppe Bandini; Andrew Campbell; Enric Carreras; Augustin Ferrant; Leanthe Grommisch; Peter Jacobs; Nicolaus Kröger; Giorgio La Nasa; Nigel Russell; Pierre Zachee; Hartmut Goldschmidt; Simona Iacobelli; Dietger Niederwieser; Gösta Gahrton
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

Review 4.  Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Authors:  Morie A Gertz; Ray Comenzo; Rodney H Falk; Jean Paul Fermand; Bouke P Hazenberg; Philip N Hawkins; Giampaolo Merlini; Philippe Moreau; Pierre Ronco; Vaishali Sanchorawala; Orhan Sezer; Alan Solomon; Giles Grateau
Journal:  Am J Hematol       Date:  2005-08       Impact factor: 10.047

5.  Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial.

Authors:  Vaishali Sanchorawala; Daniel G Wright; Michael Rosenzweig; Kathleen T Finn; Salli Fennessey; Jerome B Zeldis; Martha Skinner; David C Seldin
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

6.  The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.

Authors:  Angela Dispenzieri; Martha Q Lacy; Steven R Zeldenrust; Suzanne R Hayman; Shaji K Kumar; Susan M Geyer; John A Lust; Jacob B Allred; Thomas E Witzig; S Vincent Rajkumar; Philip R Greipp; Stephen J Russell; Brian Kabat; Morie A Gertz
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

7.  Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

Authors:  Giovanni Palladini; Vittorio Perfetti; Laura Obici; Riccardo Caccialanza; Alessandra Semino; Fausto Adami; Giobatta Cavallero; Roberto Rustichelli; Giovambattista Virga; Giampaolo Merlini
Journal:  Blood       Date:  2003-12-18       Impact factor: 22.113

8.  High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.

Authors:  Martha Skinner; Vaishali Sanchorawala; David C Seldin; Laura M Dember; Rodney H Falk; John L Berk; Jennifer J Anderson; Carl O'Hara; Kathleen T Finn; Caryn A Libbey; Janice Wiesman; Karen Quillen; Niall Swan; Daniel G Wright
Journal:  Ann Intern Med       Date:  2004-01-20       Impact factor: 25.391

9.  Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma.

Authors:  N Kröger; W Krüger; H Renges; T Zabelina; N Stute; R Jung; G Wittkowsky; R Kuse; A Zander
Journal:  Br J Haematol       Date:  2001-02       Impact factor: 6.998

10.  Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability.

Authors:  Tilmann Bochtler; Ute Hegenbart; Friedrich W Cremer; Christiane Heiss; Axel Benner; Dirk Hose; Marion Moos; Jelena Bila; Claus R Bartram; Anthony D Ho; Hartmut Goldschmidt; Anna Jauch; Stefan O Schonland
Journal:  Blood       Date:  2008-02-27       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.